nanopore sequencing
The company’s research-use-only AmplideX Nanopore Carrier Plus kit can interrogate 11 genes underpinning nine common carrier screening conditions.
Building on previous research, the team has developed the test and implemented it clinically throughout Europe.
Gates Foundation Awards Multiple Omics, Dx Grants in April, May
Awardees include the National Institute of Standards and Technology, Detect-Ion, the US Food and Drug Administration, and the Wellcome Sanger Institute.
Renovaro Subsidiary GediCube to Acquire Majority of Liquid Biopsy Firm Cyclomics
The combined companies will advance Cyclomics' platform for cancer screening, recurrence detection, and therapy personalization.
Garvan Institute Gets A$11.6M From Australian Government to Develop Genomics-Based Disease Tests
Four teams will use genomics to improve the diagnosis and treatment of diseases including Parkinson's, inflammatory bowel disease, and rare genetic disorders.